LeMaitre Vascular, Inc. (LMAT)
80.67
+0.18
(+0.22%)
USD |
NASDAQ |
Sep 04, 16:00
80.71
+0.04
(+0.05%)
After-Hours: 20:00
LeMaitre Vascular Total Liabilities (Quarterly) : 220.21M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 220.21M |
| March 31, 2026 | 222.90M |
| December 31, 2025 | 222.17M |
| September 30, 2025 | 219.15M |
| June 30, 2025 | 214.90M |
| March 31, 2025 | 208.43M |
| December 31, 2024 | 214.53M |
| September 30, 2024 | 45.95M |
| June 30, 2024 | 43.55M |
| March 31, 2024 | 45.45M |
| December 31, 2023 | 48.88M |
| September 30, 2023 | 45.38M |
| June 30, 2023 | 42.64M |
| March 31, 2023 | 40.70M |
| December 31, 2022 | 42.28M |
| September 30, 2022 | 40.80M |
| June 30, 2022 | 41.39M |
| March 31, 2022 | 34.67M |
| December 31, 2021 | 38.65M |
| September 30, 2021 | 40.42M |
| June 30, 2021 | 60.67M |
| March 31, 2021 | 69.84M |
| December 31, 2020 | 80.24M |
| September 30, 2020 | 100.59M |
| June 30, 2020 | 103.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 35.72M |
| December 31, 2019 | 40.20M |
| September 30, 2019 | 27.70M |
| June 30, 2019 | 25.12M |
| March 31, 2019 | 27.16M |
| December 31, 2018 | 22.85M |
| September 30, 2018 | 18.98M |
| June 30, 2018 | 16.36M |
| March 31, 2018 | 15.94M |
| December 31, 2017 | 16.55M |
| September 30, 2017 | 15.16M |
| June 30, 2017 | 13.74M |
| March 31, 2017 | 14.90M |
| December 31, 2016 | 14.42M |
| September 30, 2016 | 14.62M |
| June 30, 2016 | 12.68M |
| March 31, 2016 | 12.76M |
| December 31, 2015 | 12.82M |
| September 30, 2015 | 12.43M |
| June 30, 2015 | 12.80M |
| March 31, 2015 | 11.65M |
| December 31, 2014 | 13.28M |
| September 30, 2014 | 16.38M |
| June 30, 2014 | 12.75M |
| March 31, 2014 | 12.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp. | 20.04B |
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 640.55M |
| Shareholders Equity (Quarterly) | 420.34M |
| Debt to Equity Ratio | 0.4526 |
| Current Ratio | 15.89 |
| Net Debt Paydown Yield | -0.04% |